MN-AM offers innovative chemoinformatics software products, consulting, development and research services to increase the quality and productivity of discoveries in chemical, pharmaceutical and R&D programs.

Founded in 1997, the technology and knowhow of MN-AM is utilized worldwide in more than 150 major industrial, governmental and academic discovery laboratories as well as in regulatory agencies to design and optimize chemical products and to support the safety and risk assessment process. The product portfolio of MN-AM comprises a variety of software and database applications in the area of computational toxicology and chemoinformatics ranging from unique knowledgebases of expert QC'ed in vivo and in vitro toxicity information to in silico predictions of chemical, physical, biological and toxicological properties of chemical compounds including their reactivity and metabolic fate. Members of MN-AM share expertise in molecular informatics, chemometrics, computational modeling and analysis and statistical design of experiments.

The MN-AM software development team has extensive experiences in systems development for internationally-funded projects, including private and public projects such as Seurat-1 COSMOS, IMI (eTOX, iPiE), IMI 2 (eTRANSAFE), and Horizon 2020 (ONTOX). 

MN-AM is also an experienced partner to develop custom-designed solutions suited to the partner's specific needs and has a unique expertise and technology to analyse and model proprietary chemical and biological data.

MN-AM

Org chart

Teams

Offices

MN-AM

Org chart

Teams

Offices

Related companies